Ulipristal Acetate Effectively Medically Manages Symptomatic Leiomyomatous Uteri
Journal Title: International Journal of Reproduction, Fertility & Sexual Health (IJRFSH) - Year 2017, Vol 4, Issue 1
Abstract
Background: Symptomatic leiomyomatous uteri affect about 30% of women. Associated anemia, dysmenorrhea, dyspareunia, heavy menstrual bleeding, and mass effects cause quality of life decrements. The 5-year levonorgestrel intrauterine device (5yr-IUD) has been a mainstay of medical management for symptomatic leiomyomata. If approved, Ulipristal acetate (UPA),which entered the European and Canadian markets in 2012 and 2013, could change medical management of symptomatic leiomyomata in the United States. Methods: PubMed search for the term “ulipristal acetate treatment fibroids” yielded five included articles. Hand search provided nine additional articles. Results: The 5yr-IUD achieves maximal amenorrhea in 70% of users at 3 months. Dysmenorrhea improves in 84% of 5yr- IUD users. A Phase III trial with 451 participants compared UPA 5 and 10 mg over four 12-week treatment cycles. At the study end, menstruation was controlled in up to 77.5% of participants, with 70% or more participants in each group achieving amenorrhea. Combined median leiomyoma volume reduction for the three largest leiomyomata reached 67.4%. Median health related QOL scores decreased from 56.9 and 55.2 respectively to 20.7 and 15.5 respectively after the fourth treatment cycle. Conclusion: UPA offers onset amenorrhea within 6 days irrespective of dose, whereas the 5yr-IUD may take 3-months to achieve amenorrhea. UPA decreases leiomyomata volume up to 65% within 1-year, but, the 5yr-IUD does not reduce leiomyomata volume. The 5yr-IUD provides simultaneous contraception, whereas UPA requires separate contraception. As there are no significant benefits to higher dose treatment, UPA 5 mg should have a place in gynecologic clinical practice.
Authors and Affiliations
Oroma B. Nwanodi
Keywords
Related Articles
- EP ID EP326239
- DOI 10.19070/2377-1887-1700016
- Views 68
- Downloads 0
Mifepristone Plus Vaginal Misoprostol V/S Vaginal Misoprostol Alone for Medical Termination of Pregnancy
Medical abortion has been investigated as a non-invasive option for early abortions as it avoids the risk of anesthesia and surgical trauma to the cervix, uterus and other organs. The main aim of the study was to compare...
Paternal Factors - Role in Idiopathic Recurrent Pregnancy Losses
Paternal Factors - Role in Idiopathic Recurrent Pregnancy Losses
Unilateral Labial Hypertrophy in Adolescents: when should we Interfere? Two Case Reports
Synopsis: Adolescent and pre-menarchal patients with symptomatic unilateral labial hypertrophy should be counselled extensively prior to surgical management regarding risks of recurrence or contralateral occurrence. Purp...
Clinical Versus Echographic Estimation of Fetal Weight at Term in A Selected Caucasian Milieu: A Comparative Analysis of The Kongnyuy – Mbu’s Clinical Estimation
Background: Estimation of fetal weight is essential in contemporary obstetrics. Clinical estimations using maternal and fetal characteristics and ultrasound methods exist. We compared a simple clinical estimation that is...
Application of the PEN-3 Cultural Model in Assessing Factors affecting Adolescent Pregnancies in Rural Eastern Cape, South Africa
Early pregnancy and child birth increases the health risk for the mother and the baby. It is a public health concern in South Africa as it may affect the health; social and economic well-being of society at large. Althou...